Deletion of 1p loci and microsatellite instability in colorectal polyps.

DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol (1999) 2.78

Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut (2000) 1.95

CpG island methylation in aberrant crypt foci of the colorectum. Am J Pathol (2002) 1.83

Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol (2003) 1.82

Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology (2008) 1.69

APC mutations are sufficient for the growth of early colorectal adenomas. Proc Natl Acad Sci U S A (2000) 1.41

BAT-26 and BAT-40 instability in colorectal adenomas and carcinomas and germline polymorphisms. Am J Pathol (1999) 1.36

BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol (2005) 1.23

Transforming growth factor-beta receptor type 2 mutations and microsatellite instability in sporadic colorectal adenomas and carcinomas. Am J Pathol (1997) 1.07

The structure of the human multiple exostoses 2 gene and characterization of homologs in mouse and Caenorhabditis elegans. Genome Res (1997) 1.03

Metaplastic (hyperplastic) polyps of the large bowel: benign neoplasms after all? Gut (1997) 1.01

Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patients. Neoplasia (2001) 0.89

A study of genomic instability in early preneoplastic colonic lesions. Oncogene (2012) 0.87

Predicting survival in head and neck squamous cell carcinoma from TP53 mutation. Hum Genet (2014) 0.84

Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis. Clin Exp Gastroenterol (2011) 0.77

Comparative molecular pathology of sporadic hyperplastic polyps and neoplastic lesions from the same individual. J Clin Pathol (2004) 0.77

Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52

Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell (1993) 9.93

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet (2000) 8.58

Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med (1998) 8.47

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology (2000) 8.41

Complete genome sequence and comparative analysis of the metabolically versatile Pseudomonas putida KT2440. Environ Microbiol (2002) 8.11

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med (1996) 7.32

Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer (1999) 6.73

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36

Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res (1993) 4.93

Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med (1996) 4.87

Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet (1995) 4.01

Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res (1994) 3.25

Is the use of dummy or carry-cot of importance for sudden infant death? Eur J Pediatr (1997) 3.06

Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology (1989) 2.98

Detection of base mutations in genomic DNA using denaturing gradient gel electrophoresis (DGGE) followed by transfer and hybridization with gene-specific probes. Mutat Res (1988) 2.94

Dual function of the selenoprotein PHGPx during sperm maturation. Science (1999) 2.93

BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75

Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med (1992) 2.64

A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group. N Engl J Med (1998) 2.54

Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci U S A (1985) 2.44

Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nat Genet (1994) 2.08

Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Am J Pathol (2000) 2.03

Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chromosomes Cancer (1992) 1.99

Microsatellite instability as an indicator of hereditary susceptibility to colon cancer. Gastroenterology (1995) 1.97

Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study. J Clin Oncol (2001) 1.97

Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res (1998) 1.89

The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Scand J Gastroenterol (2003) 1.87

Whole-arm t(1;16) and i(1q) as sole anomalies identify gain of 1q as a primary chromosomal abnormality in breast cancer. Genes Chromosomes Cancer (1992) 1.86

MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis. Genes Chromosomes Cancer (1997) 1.83

Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Observer variation and correlations. Gastroenterology (1988) 1.81

Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn's disease of the colon. Gastroenterology (1987) 1.76

Familial testicular cancer in Norway and southern Sweden. Br J Cancer (1996) 1.76

Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res (1994) 1.70

Growth of colorectal polyps: recovery and evaluation of unresected polyps of less than 10 mm, 1 year after detection. Scand J Gastroenterol (1994) 1.66

DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet (1996) 1.64

Molecular heterogeneity in the mild autosomal dominant forms of osteogenesis imperfecta. Am J Hum Genet (1984) 1.62

Insights into the genomic basis of niche specificity of Pseudomonas putida KT2440. Environ Microbiol (2004) 1.61

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Lymphoepithelial interactions in the mucosal immune system. Gut (1988) 1.58

Germline and somatic mutations in exon 15 of the APC gene and K-ras mutations in duodenal adenomas in patients with familial adenomatous polyposis. Scand J Gastroenterol (1999) 1.58

Age and origin of two common MLH1 mutations predisposing to hereditary colon cancer. Am J Hum Genet (1996) 1.58

Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer (1997) 1.57

Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas. Hum Mol Genet (1995) 1.57

WNT1 inducible signaling pathway protein 3, WISP-3, a novel target gene in colorectal carcinomas with microsatellite instability. Gastroenterology (2001) 1.56

Does preoperative anxiety influence gastric fluid volume and acidity? Anesth Analg (1992) 1.53

Molecular genetic changes in human male germ cell tumors. Lab Invest (1995) 1.53

Evidence of phosphorylated phosphatidylinositols in the growth cycle of suspension cultured plant cells. Biochem Biophys Res Commun (1986) 1.52

Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years. Gut (1996) 1.50

Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction. Int J Cancer (2000) 1.49

Karyotypic characterization of colorectal adenocarcinomas. Genes Chromosomes Cancer (1995) 1.48

The incidence of complications in endoscopic anterior thoracolumbar spinal reconstructive surgery. A prospective multicenter study comprising the first 100 consecutive cases. Spine (Phila Pa 1976) (1995) 1.48

Objective measurements of nicotine exposure in victims of sudden infant death syndrome and in other unexpected child deaths. J Pediatr (1998) 1.46

The human gastrointestinal secretory immune system in health and disease. Scand J Gastroenterol Suppl (1985) 1.44

Comparative epidemiology of sudden infant death syndrome and sudden intrauterine unexplained death. Arch Dis Child Fetal Neonatal Ed (2002) 1.43

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Trisomy 7 in short-term cultures of colorectal adenocarcinomas. Genes Chromosomes Cancer (1991) 1.41

High-density lipoprotein as carrier for amyloid-related protein SAA in rabbit serum. Scand J Immunol (1979) 1.41

Marfan syndrome: exclusion of genetic linkage to the COL1A2 gene. Clin Genet (1986) 1.40

Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer. Cancer Res (1996) 1.40

Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology. Pharmacogenetics (1995) 1.39

New chromosomal rearrangement, t(12;22)(p13;q12), in acute nonlymphocytic leukemia. Cancer Genet Cytogenet (1991) 1.39

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

[Sudden infant death and sleeping position]. Tidsskr Nor Laegeforen (1992) 1.38

Fluorescence in situ hybridization of old G-banded and mounted chromosome preparations. Cancer Genet Cytogenet (1997) 1.38

Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res (2000) 1.38

Genetics of hereditary colon cancer. Annu Rev Genet (1995) 1.36

A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden. Cancer Detect Prev (1994) 1.36

Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34

Evaluation of tissue preparation methods and paired immunofluorescence staining for immunocytochemistry of lymphomas. Histochem J (1983) 1.34

Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes Cancer (1992) 1.34

Deletion of 1p36 as a primary chromosomal aberration in intestinal tumorigenesis. Cancer Res (1993) 1.32

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location. Br J Cancer (1994) 1.31

A segregation analysis of testicular cancer based on Norwegian and Swedish families. Br J Cancer (1997) 1.31

Three major cytogenetic subgroups can be identified among chromosomally abnormal solitary lipomas. Hum Genet (1988) 1.30

Clonal heterogeneity in breast cancer: karyotypic comparisons of multiple intra- and extra-tumorous samples from 3 patients. Int J Cancer (1995) 1.30

Prognostic significance of TP53 alterations in breast carcinoma. Br J Cancer (1993) 1.30

Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease. J Intern Med (2004) 1.29

Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol (2004) 1.28

Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers. Proc Natl Acad Sci U S A (1999) 1.28

Lipomas have characteristic structural chromosomal rearrangements of 12q13-q14. Int J Cancer (1987) 1.28

Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer (1995) 1.28

The InSiGHT database: utilizing 100 years of insights into Lynch syndrome. Fam Cancer (2013) 1.27

Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27

Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut (2005) 1.26

Cerebral symptoms after whiplash injury of the neck: a prospective clinical and neuropsychological study of whiplash injury. J Neurol Neurosurg Psychiatry (1992) 1.24

Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Genes Chromosomes Cancer (1992) 1.22

In situ measurement of colorectal polyps to compare video and fiberoptic endoscopes. Endoscopy (1994) 1.21

Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cancer Res (1994) 1.21